Baiyi Pharma receives approval for clinical trials of mannitol sorbitol injection

Summary: On 8 Aug., Weixinkang Medicine announced that its wholly-owned subsidiary, Baiyi Pharma, had received a notification letter from the NMPA, approving to proceed with clinical trials for its mannitol sorbitol injection.On 8 Aug., Tibet Weixink...

Sorbitol China News 202408

www.cnchemicals.com